Sort   by:  
 Page size 
UnknownMutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
Not available
S-EPMC3363329 | biostudies-literature
TranscriptomicsRNA-binding protein AUF1 promotes myogenesis by regulating MEF2C expression levels
The mammalian RNA-binding protein AUF1 (AU-binding factor 1, also known as heterogeneous nuclear ribonucleoprotein D, hnRNP D) binds to numerous mRNAs and influences their post-transcriptional fate. Given that many AUF1 target mRNAs encode muscle-specific factors, we investigated the function of AU...
ORGANISM(S): Mus musculus 
2014-12-22 | E-GEOD-58259 | biostudies-arrayexpress
UnknownInterleukin-17 enhances immunosuppression by mesenchymal stem cells.
Not available
S-EPMC4211372 | biostudies-literature
ProteomicsDAP5 directs a widespread alternate form of cap-dependent mRNA translation initiation using eIF3d for specialized cell functions
Affinity purification of eIF4GII, eIF4GI and DAP5 using a HA tag on the N-terminus of each protein.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2018-05-25 | MSV000082407 | MassIVE
UnknownThe KMT2A recombinome of acute leukemias in 2023.
Not available
S-EPMC10169636 | biostudies-literature
UnknownPrognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.
Not available
S-EPMC11825916 | biostudies-literature
UnknownIndividual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.
Not available
S-EPMC10205601 | biostudies-literature
UnknownThe type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Not available
S-EPMC10803270 | biostudies-literature
UnknownCircuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
Not available
S-EPMC7987233 | biostudies-literature
UnknownThe recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
Not available
S-EPMC10996746 | biostudies-literature
Sort   by:  
 Page size